|
| 37713477 | Comparative Effectiveness of Aspirin Dosing in Cardiovascular Disease and Diabetes Mellitus: A Subgroup Analysis of the ADAPTABLE Trial. | Diabetes Care | 2024 |
| 37098746 | Leveraging electronic health records to streamline the conduct of cardiovascular clinical trials. | Eur Heart J | 2023 |
| 37792369 | Effectiveness and Safety of Enteric-Coated vs Uncoated Aspirin in Patients With Cardiovascular Disease: A Secondary Analysis of the ADAPTABLE Randomized Clinical Trial. | JAMA Cardiol | 2023 |
| 35339451 | Preexisting frailty and outcomes in older patients with acute myocardial infarction. | Am Heart J | 2022 |
| 35835600 | Outcomes After Acute Coronary Syndrome in Patients With Diabetes Mellitus and Peripheral Artery Disease (from the TRACER, TRILOGY-ACS, APPRAISE-2, and PLATO Clinical Trials). | Am J Cardiol | 2022 |
| 35483759 | The National Cardiovascular Data Registry Data Quality Program 2020: JACC State-of-the-Art Review. | J Am Coll Cardiol | 2022 |
| 35112882 | Cardiovascular Events and Long-Term Risk of Sudden Death Among Stabilized Patients After Acute Coronary Syndrome: Insights From IMPROVE-IT. | J Am Heart Assoc | 2022 |
| 32558693 | Effect of intervention timing on one-year mortality in elderly non-ST-segment elevation myocardial infarction patients. | Coron Artery Dis | 2021 |
| 33755145 | Intensity of statin treatment after acute coronary syndrome, residual risk, and its modification by alirocumab: insights from the ODYSSEY OUTCOMES trial. | Eur J Prev Cardiol | 2021 |
| 34459214 | Cardiovascular Safety of Degarelix Versus Leuprolide in Patients With Prostate Cancer: The Primary Results of the PRONOUNCE Randomized Trial. | Circulation | 2021 |
| 34132992 | Post-COVID-19 Syndrome: Leveraging the Patient Perspective and Technological Innovations to Enable the Delineation of Effective Treatments. | Drugs | 2021 |
| 34297072 | Assessment of North American Clinical Research Site Performance During the Start-up of Large Cardiovascular Clinical Trials. | JAMA Netw Open | 2021 |
| 34120618 | Enabling patient-reported outcome measures in clinical trials, exemplified by cardiovascular trials. | Health Qual Life Outcomes | 2021 |
| 33999548 | Comparative Effectiveness of Aspirin Dosing in Cardiovascular Disease. | N Engl J Med | 2021 |
| 30879969 | Androgen deprivation therapy and cardiovascular disease. | Urol Oncol | 2020 |
| 34396210 | Cardiovascular Safety of Degarelix Versus Leuprolide for Advanced Prostate Cancer: The PRONOUNCE Trial Study Design. | JACC CardioOncol | 2020 |
| 31732742 | Effect of alirocumab on cardiovascular outcomes after acute coronary syndromes according to age: an ODYSSEY OUTCOMES trial analysis. | Eur Heart J | 2020 |
| 32081368 | Meta-Analysis of Intraocular Bleeding With Dual Antiplatelet Therapy Using P2Y12 Inhibitors Prasugrel or Ticagrelor. | Am J Cardiol | 2020 |
| 31992065 | Impact of Regulatory Guidance on Evaluating Cardiovascular Risk of New Glucose-Lowering Therapies to Treat Type 2 Diabetes Mellitus: Lessons Learned and Future Directions. | Circulation | 2020 |
| 31948641 | Effect of Alirocumab on Lipoprotein(a) and Cardiovascular Risk After Acute Coronary Syndrome. | J Am Coll Cardiol | 2020 |
| 32862694 | Long-Term Bleeding Risk Prediction with Dual Antiplatelet Therapy After Acute Coronary Syndromes Treated Without Revascularization. | Circ Cardiovasc Qual Outcomes | 2020 |
| 32768631 | Drug Development in Kidney Disease: Proceedings From a Multistakeholder Conference. | Am J Kidney Dis | 2020 |
| 32646565 | Post-Discharge Bleeding and Mortality Following Acute Coronary Syndromes With or Without PCI. | J Am Coll Cardiol | 2020 |
| 32615793 | University of Pennsylvania 12th annual conference on statistical issues in clinical trials: Electronic health records in randomized clinical trials-challenges and opportunities (morning panel session). | Clin Trials | 2020 |
| 32668979 | Leveraging electronic health record data for pragmatic randomized trials. | Clin Trials | 2020 |
| 32416181 | Elevated Uric Acid Prevalence and Clinical Outcomes in Patients with Heart Failure with Preserved Ejection Fraction: Insights from RELAX. | Am J Med | 2020 |
| 32386813 | Comparison of Characteristics and Outcomes of Patients With Heart Failure With Preserved Ejection Fraction With Versus Without Hyperuricemia or Gout. | Am J Cardiol | 2020 |
| 32277149 | Circulating MicroRNA Profiling in Non-ST Elevated Coronary Artery Syndrome Highlights Genomic Associations with Serial Platelet Reactivity Measurements. | Sci Rep | 2020 |
| 32498620 | Study Design and Rationale of EXPLORER-HCM: Evaluation of Mavacamten in Adults With Symptomatic Obstructive Hypertrophic Cardiomyopathy. | Circ Heart Fail | 2020 |
| 32466729 | Computable Phenotype Implementation for a National, Multicenter Pragmatic Clinical Trial: Lessons Learned From ADAPTABLE. | Circ Cardiovasc Qual Outcomes | 2020 |
| 32381160 | Cost-Effectiveness of Alirocumab in Patients With Acute Coronary Syndromes: The ODYSSEY OUTCOMES Trial. | J Am Coll Cardiol | 2020 |
| 32514736 | Designing, Conducting, Monitoring, and Analyzing Data from Pragmatic Randomized Clinical Trials: Proceedings from a Multi-stakeholder Think Tank Meeting. | Ther Innov Regul Sci | 2020 |
| 32223446 | Peripheral Artery Disease and Venous Thromboembolic Events After Acute Coronary Syndrome: Role of Lipoprotein(a) and Modification by Alirocumab: Prespecified Analysis of the ODYSSEY OUTCOMES Randomized Clinical Trial. | Circulation | 2020 |
| 32479416 | Differential Longitudinal Outcomes Following Percutaneous Coronary Intervention to the Left Internal Mammary Artery and Other Bypass Grafts of the LAD: Findings From the NCDR. | J Invasive Cardiol | 2020 |
| 32368697 | Targeting Vascular Calcification in Chronic Kidney Disease. | JACC Basic Transl Sci | 2020 |
| 30586696 | Relationship Between Operator Volume and Long-Term Outcomes After Percutaneous Coronary Intervention. | Circulation | 2019 |
| 31701037 | Improving and sustaining the site investigator community: Recommendations from the Clinical Trials Transformation Initiative. | Contemp Clin Trials Commun | 2019 |
| 31726314 | Claims-based cardiovascular outcome identification for clinical research: Results from 7 large randomized cardiovascular clinical trials. | Am Heart J | 2019 |
| 31890985 | Continued investigator engagement: Reasons principal investigators conduct multiple FDA-regulated drug trials. | Contemp Clin Trials Commun | 2019 |
| 31657956 | Addressing the Conundrum of Bleeding and Cancer Detection With Antithrombotic Therapies for Chronic Atherosclerotic Cardiovascular Disease. | Circulation | 2019 |
| 31707826 | Alirocumab Reduces Total Hospitalizations and Increases Days Alive and Out of Hospital in the ODYSSEY OUTCOMES Trial. | Circ Cardiovasc Qual Outcomes | 2019 |
| 31707788 | Effect of Alirocumab on Stroke in ODYSSEY OUTCOMES. | Circulation | 2019 |
| 30217419 | Seasonal and circadian patterns of myocardial infarction by coronary artery disease status and sex in the ACTION Registry-GWTG. | Int J Cardiol | 2019 |
| 31272931 | Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial. | Lancet Diabetes Endocrinol | 2019 |
| 31530226 | Associations of osteopontin and NT-proBNP with circulating miRNA levels in acute coronary syndrome. | Physiol Genomics | 2019 |
| 31466614 | Effects of Alirocumab on Cardiovascular Events After Coronary Bypass Surgery. | J Am Coll Cardiol | 2019 |
| 31462138 | Association of Cognitive Impairment With Treatment and Outcomes in Older Myocardial Infarction Patients: A Report From the NCDR Chest Pain-MI Registry. | J Am Heart Assoc | 2019 |
| 31234037 | Hospital participation in clinical trials for patients with acute myocardial infarction: Results from the National Cardiovascular Data Registry. | Am Heart J | 2019 |
| 31487564 | Longitudinal low density lipoprotein cholesterol goal achievement and cardiovascular outcomes among adult patients with familial hypercholesterolemia: The CASCADE FH registry. | Atherosclerosis | 2019 |
| 31545683 | Revisiting the Role of Aspirin for the Primary Prevention of Cardiovascular Disease. | Circulation | 2019 |